Multicenter Phase 2 Trial of Rituximab for Waldenström Macroglobulinemia (WM): An Eastern Cooperative Oncology Group Study (E3A98)
Loading...
Date
2004
Other authors
Impact
Journal Title
Journal ISSN
Volume Title
Related resource
Citation
Journal or Serie
Leukemia & Lymphoma, 2004, vol. 45, núm. 10, p. 2047-2055